{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,12]],"date-time":"2026-05-12T13:15:56Z","timestamp":1778591756775,"version":"3.51.4"},"reference-count":35,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2021,1,1]],"date-time":"2021-01-01T00:00:00Z","timestamp":1609459200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2021,1,1]],"date-time":"2021-01-01T00:00:00Z","timestamp":1609459200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2022,1,13]],"date-time":"2022-01-13T00:00:00Z","timestamp":1642032000000},"content-version":"am","delay-in-days":377,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"}],"funder":[{"DOI":"10.13039\/100000738","name":"U.S. Department of Veterans Affairs","doi-asserted-by":"publisher","award":["1 I01 HX 002090-01A2"],"award-info":[{"award-number":["1 I01 HX 002090-01A2"]}],"id":[{"id":"10.13039\/100000738","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000005","name":"U.S. Department of Defense","doi-asserted-by":"publisher","award":["150092"],"award-info":[{"award-number":["150092"]}],"id":[{"id":"10.13039\/100000005","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Clinical Densitometry"],"published-print":{"date-parts":[[2021,1]]},"DOI":"10.1016\/j.jocd.2019.06.003","type":"journal-article","created":{"date-parts":[[2019,6,14]],"date-time":"2019-06-14T21:26:05Z","timestamp":1560547565000},"page":"67-77","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":3,"title":["Reasons for Initiation and Discontinuation of Pharmacological Therapies for Osteoporosis in Veterans with Spinal Cord Injury and Disorders"],"prefix":"10.1016","volume":"24","author":[{"given":"Brian","family":"Le","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Cara","family":"Ray","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Beverly","family":"Gonzalez","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Scott","family":"Miskevics","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Frances M.","family":"Weaver","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Michael","family":"Priebe","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Laura D.","family":"Carbone","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.jocd.2019.06.003_bib0001","unstructured":"U.S. Department of Veterans Affairs. VHA Handbook 1176.01: Spinal Cord Injury and Disorderes (SCI\/D) System of Care. Available at: http:\/\/www.va.gov\/whapublications\/ViewPublication.asp?pub_ID-2365. Accessed: December 15."},{"key":"10.1016\/j.jocd.2019.06.003_bib0002","unstructured":"National Spinal Cord Injury Statistical Center, Birmingham, Alabama. Spinal Cord Injury Facts and Figures at a Glance. Available at: https:\/\/www.nscisc.uab.edu\/PublicDocuments\/...\/Facts%202012%20Feb%20Final.pdf. Accessed: May 3, 2017."},{"issue":"3","key":"10.1016\/j.jocd.2019.06.003_bib0003","doi-asserted-by":"crossref","first-page":"925","DOI":"10.1007\/s00198-016-3841-y","article-title":"Dual-energy X-ray absorptiometry and fracture prediction in patients with spinal cord injuries and disorders","volume":"28","author":"Abderhalden","year":"2017","journal-title":"Osteoporos Int"},{"issue":"8","key":"10.1016\/j.jocd.2019.06.003_bib0004","doi-asserted-by":"crossref","first-page":"2261","DOI":"10.1007\/s00198-013-2295-8","article-title":"Morbidity following lower extremity fractures in men with spinal cord injury","volume":"24","author":"Carbone","year":"2013","journal-title":"Osteoporos Int"},{"issue":"2","key":"10.1016\/j.jocd.2019.06.003_bib0005","doi-asserted-by":"crossref","first-page":"432","DOI":"10.1002\/jbmr.2050","article-title":"Mortality after lower extremity fractures in men with spinal cord injury","volume":"29","author":"Carbone","year":"2014","journal-title":"J Bone Miner Res"},{"issue":"5","key":"10.1016\/j.jocd.2019.06.003_bib0006","doi-asserted-by":"crossref","first-page":"555","DOI":"10.1111\/j.1365-2265.2006.02683.x","article-title":"Mechanisms of osteoporosis in spinal cord injury","volume":"65","author":"Jiang","year":"2006","journal-title":"Clin Endocrinol (Oxf)"},{"issue":"10","key":"10.1016\/j.jocd.2019.06.003_bib0007","doi-asserted-by":"crossref","first-page":"e25900","DOI":"10.1371\/journal.pone.0025900","article-title":"Sclerostin stimulates osteocyte support of osteoclast activity by a RANKL-dependent pathway","volume":"6","author":"Wijenayaka","year":"2011","journal-title":"PLoS One"},{"issue":"11","key":"10.1016\/j.jocd.2019.06.003_bib0008","doi-asserted-by":"crossref","first-page":"e81124","DOI":"10.1371\/journal.pone.0081124","article-title":"Effectiveness of bisphosphonate analogues and functional electrical stimulation on attenuating post-injury osteoporosis in spinal cord injury patients- a systematic review and meta-analysis","volume":"8","author":"Chang","year":"2013","journal-title":"PLoS One"},{"issue":"3","key":"10.1016\/j.jocd.2019.06.003_bib0009","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1080\/10790268.2009.11760776","article-title":"Bisphosphonate use in acute and chronic spinal cord injury: a systematic review","volume":"32","author":"Bryson","year":"2009","journal-title":"J Spinal Cord Med"},{"issue":"7","key":"10.1016\/j.jocd.2019.06.003_bib0010","doi-asserted-by":"crossref","first-page":"1067","DOI":"10.1359\/JBMR.040313","article-title":"Prevention of bone loss in paraplegics over 2 years with alendronate","volume":"19","author":"Zehnder","year":"2004","journal-title":"J Bone Miner Res"},{"issue":"6","key":"10.1016\/j.jocd.2019.06.003_bib0011","doi-asserted-by":"crossref","first-page":"341","DOI":"10.1038\/sj.sc.3101725","article-title":"Effect of alendronate on bone mineral density in spinal cord injury patients: a pilot study","volume":"43","author":"Moran de Brito","year":"2005","journal-title":"Spinal Cord"},{"issue":"1","key":"10.1016\/j.jocd.2019.06.003_bib0012","doi-asserted-by":"crossref","first-page":"271","DOI":"10.1007\/s00198-010-1221-6","article-title":"Early treatment with zoledronic acid prevents bone loss at the hip following acute spinal cord injury","volume":"22","author":"Bubbear","year":"2011","journal-title":"Osteoporos Int"},{"key":"10.1016\/j.jocd.2019.06.003_bib0013","first-page":"1046","article-title":"Use of alendronate in management of osteoporosis following spinal cord injury: a report of 4 cases","volume":"19","author":"Bubbear","year":"2006","journal-title":"J Bone Miner Res"},{"issue":"1","key":"10.1016\/j.jocd.2019.06.003_bib0014","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1053\/apmr.2002.26828","article-title":"Alendronate increases bone density in chronic spinal cord injury: a case report","volume":"83","author":"Sniger","year":"2002","journal-title":"Arch Phys Med Rehabil"},{"issue":"4","key":"10.1016\/j.jocd.2019.06.003_bib0015","doi-asserted-by":"crossref","first-page":"1385","DOI":"10.1210\/jc.2006-2013","article-title":"Alendronate prevents bone loss in patients with acute spinal cord injury: a randomized, double-blind, placebo-controlled study","volume":"92","author":"Gilchrist","year":"2007","journal-title":"J Clin Endocrinol Metab"},{"issue":"4","key":"10.1016\/j.jocd.2019.06.003_bib0016","doi-asserted-by":"crossref","first-page":"410","DOI":"10.1007\/s00774-014-0602-x","article-title":"Zoledronic acid administration failed to prevent bone loss at the knee in persons with acute spinal cord injury: an observational cohort study","volume":"33","author":"Bauman","year":"2015","journal-title":"J Bone Miner Metab"},{"issue":"1","key":"10.1016\/j.jocd.2019.06.003_bib0017","doi-asserted-by":"crossref","first-page":"2","DOI":"10.1179\/2045772313Y.0000000156","article-title":"A retrospective review of lower extremity fracture care in patients with spinal cord injury","volume":"38","author":"Akhigbe","year":"2015","journal-title":"J Spinal Cord Med"},{"key":"10.1016\/j.jocd.2019.06.003_bib0018","doi-asserted-by":"crossref","first-page":"e3211","DOI":"10.1136\/bmj.e3211","article-title":"Bisphosphonates in the treatment of osteoporosis","volume":"344","author":"Kenneth","year":"2012","journal-title":"BMJ"},{"issue":"3","key":"10.1016\/j.jocd.2019.06.003_bib0019","doi-asserted-by":"crossref","first-page":"254","DOI":"10.1056\/NEJMcp1513724","article-title":"Clinical Practice. Postmenopausal osteoporosis","volume":"374","author":"Black","year":"2016","journal-title":"N Engl J Med"},{"issue":"4","key":"10.1016\/j.jocd.2019.06.003_bib0020","first-page":"324","article-title":"Bisphosphonates for treatment of osteoporosis: expected benefits, potential harms, and drug holidays","volume":"60","author":"Brown","year":"2014","journal-title":"Can Fam Physician"},{"issue":"11","key":"10.1016\/j.jocd.2019.06.003_bib0021","doi-asserted-by":"crossref","first-page":"1613","DOI":"10.1007\/s00198-008-0604-4","article-title":"Risk of hip fracture after bisphosphonate discontinuation: implications for a drug holiday","volume":"19","author":"Curtis","year":"2008","journal-title":"Osteoporos Int"},{"issue":"8","key":"10.1016\/j.jocd.2019.06.003_bib0022","doi-asserted-by":"crossref","first-page":"679","DOI":"10.1682\/JRRD.2009.08.0117","article-title":"Using VA data for research in persons with spinal cord injuries and disorders: lessons from SCI QUERI","volume":"47","author":"Smith","year":"2010","journal-title":"J Rehabil Res Dev"},{"key":"10.1016\/j.jocd.2019.06.003_bib0023","unstructured":"U.S. Centers for Medicare and Medicaid Services. Bone Density Test Coverage. Available at: https:\/\/www.medicare.gov\/coverage\/bone-mass-measurements. Accessed: February 11, 2019."},{"key":"10.1016\/j.jocd.2019.06.003_bib0024","unstructured":"World Health Organization (WHO) Collaborating Centre for Metabolic Bone Disease, University of Sheffield, UK. FRAX: Fracture Risk Assessment Tool. Available at: https:\/\/www.sheffield.ac.uk\/FRAX\/tool.aspx?country=31. Accessed: March 3, 2018."},{"key":"10.1016\/j.jocd.2019.06.003_bib0025","doi-asserted-by":"crossref","first-page":"1","DOI":"10.2147\/CIA.S97593","article-title":"Physicians' perspectives on the treatment of osteoporosis patients with bisphosphonates","volume":"11","author":"Gu","year":"2016","journal-title":"Clin Interv Aging"},{"issue":"7","key":"10.1016\/j.jocd.2019.06.003_bib0026","doi-asserted-by":"crossref","first-page":"699","DOI":"10.1111\/dote.12272","article-title":"Greatly increased prevalence of esophageal dysmotility observed in persons with spinal cord injury","volume":"28","author":"Radulovic","year":"2015","journal-title":"Dis Esophagus"},{"issue":"1","key":"10.1016\/j.jocd.2019.06.003_bib0027","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1080\/10790268.2000.11753504","article-title":"Gastroesophageal reflux disease in patients with spinal cord injury","volume":"23","author":"Singh","year":"2000","journal-title":"J Spinal Cord Med"},{"issue":"1","key":"10.1016\/j.jocd.2019.06.003_bib0028","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1002\/jbmr.2708","article-title":"Managing osteoporosis in patients on long-term bisphosphonate Treatment: report of a task force of the American Society for Bone and Mineral Research","volume":"31","author":"Adler","year":"2016","journal-title":"J Bone Miner Res"},{"issue":"5","key":"10.1016\/j.jocd.2019.06.003_bib0029","doi-asserted-by":"crossref","first-page":"1677","DOI":"10.1007\/s00198-016-3553-3","article-title":"Cancel the denosumab holiday","volume":"27","author":"McClung","year":"2016","journal-title":"Osteoporos Int"},{"issue":"4","key":"10.1016\/j.jocd.2019.06.003_bib0030","doi-asserted-by":"crossref","first-page":"361","DOI":"10.1177\/0269215513501905","article-title":"Incidence of skeletal fractures after traumatic spinal cord injury: a 10-year follow-up study","volume":"28","author":"Gifre","year":"2014","journal-title":"Clin Rehabil"},{"key":"10.1016\/j.jocd.2019.06.003_bib0031","doi-asserted-by":"crossref","first-page":"122","DOI":"10.1016\/j.bone.2016.07.019","article-title":"A randomized, double-blind, multicenter, placebo-controlled study to evaluate the efficacy and safety of oral salmon calcitonin in the treatment of osteoporosis in postmenopausal women taking calcium and vitamin d","volume":"91","author":"Henriksen","year":"2016","journal-title":"Bone"},{"issue":"2","key":"10.1016\/j.jocd.2019.06.003_bib0032","doi-asserted-by":"crossref","first-page":"233","DOI":"10.1007\/s00774-009-0123-1","article-title":"Teriparatide is safe and effectively increases bone biomarkers in institutionalized individuals with osteoporosis","volume":"28","author":"Ryder","year":"2010","journal-title":"J Bone Miner Metab"},{"issue":"8","key":"10.1016\/j.jocd.2019.06.003_bib0033","doi-asserted-by":"crossref","first-page":"663","DOI":"10.1016\/j.pmrj.2013.03.032","article-title":"Effect of parathyroid hormone combined with gait training on bone density and bone architecture in people with chronic spinal cord injury","volume":"5","author":"Gordon","year":"2013","journal-title":"PM R"},{"issue":"10","key":"10.1016\/j.jocd.2019.06.003_bib0034","doi-asserted-by":"crossref","first-page":"1729","DOI":"10.1002\/jbmr.3525","article-title":"Effects of teriparatide and vibration on bone mass and bone strength in people with bone loss and spinal cord Injury: a Randomized, controlled trial","volume":"33","author":"Edwards","year":"2018","journal-title":"J Bone Miner Res"},{"issue":"6","key":"10.1016\/j.jocd.2019.06.003_bib0035","doi-asserted-by":"crossref","first-page":"1099","DOI":"10.1016\/j.apmr.2017.12.036","article-title":"Evaluating the use of medicare part d in the veteran population with spinal cord injury\/disorder","volume":"99","author":"Hatch","year":"2018","journal-title":"Arch Phys Med Rehabil"}],"container-title":["Journal of Clinical Densitometry"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1094695019300551?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1094695019300551?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,5,12]],"date-time":"2026-05-12T12:44:28Z","timestamp":1778589868000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1094695019300551"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,1]]},"references-count":35,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2021,1]]}},"alternative-id":["S1094695019300551"],"URL":"https:\/\/doi.org\/10.1016\/j.jocd.2019.06.003","relation":{},"ISSN":["1094-6950"],"issn-type":[{"value":"1094-6950","type":"print"}],"subject":[],"published":{"date-parts":[[2021,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Reasons for Initiation and Discontinuation of Pharmacological Therapies for Osteoporosis in Veterans with Spinal Cord Injury and Disorders","name":"articletitle","label":"Article Title"},{"value":"Journal of Clinical Densitometry","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jocd.2019.06.003","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Published by Elsevier Inc. on behalf of The International Society for Clinical Densitometry.","name":"copyright","label":"Copyright"}]}}